YER152C Antibody

What is YER152C and why would researchers study it?

YER152C is a protein found in Saccharomyces cerevisiae (strain ATCC 204508 / S288c), commonly known as Baker's yeast. Researchers study this protein and use antibodies against it to investigate various aspects of yeast biology, including protein expression, localization, and function. Antibodies targeting YER152C allow for specific detection and quantification of this protein in experimental systems . Yeast proteins like YER152C are often studied as models for understanding conserved cellular processes that may have relevance to human biology.

What applications are YER152C antibodies suitable for?

Based on available product information, YER152C antibodies have been tested and validated for several research applications:

• ELISA (Enzyme-Linked Immunosorbent Assay): For quantitative detection of YER152C protein in samples

• Western Blot (WB): For identification and semi-quantitative analysis of the target protein

• Other potential applications may include immunohistochemistry, immunoprecipitation, and immunofluorescence, though these would need validation specific to the antibody being used

Each application requires specific optimization conditions, and researchers should verify the antibody's performance in their particular experimental system.

How should YER152C antibodies be stored and handled to maintain activity?

Proper storage and handling of YER152C antibodies is crucial for maintaining their activity and specificity:

• Upon receipt, store at -20°C or -80°C

• Avoid repeated freeze-thaw cycles, which can degrade antibody quality

• YER152C antibodies are typically provided in a liquid form with a storage buffer containing:

  • Preservative: 0.03% Proclin 300

  • Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Working aliquots can be prepared to minimize freeze-thaw cycles. When removing from storage, thaw antibodies on ice and centrifuge briefly before opening to collect all material at the bottom of the tube.

What controls should be included when using YER152C antibodies in experiments?

When designing experiments with YER152C antibodies, several controls should be included:

• Positive control: Samples known to contain YER152C protein (e.g., wild-type S. cerevisiae lysate)

• Negative control: Samples known not to contain YER152C (e.g., YER152C knockout yeast strains)

• Secondary antibody-only control: To identify non-specific binding of detection antibodies

• Isotype control: Using a non-specific rabbit IgG at the same concentration to identify non-specific binding

• Loading/housekeeping controls: When performing Western blots, include detection of a housekeeping protein to ensure equal loading

These controls are essential for proper interpretation of results and troubleshooting when unexpected results occur.

How can cross-reactivity of YER152C antibodies with other proteins be assessed and mitigated?

Cross-reactivity is a common concern when working with antibodies, particularly polyclonal antibodies like those raised against YER152C:

• Assessment methods:

  • Perform Western blots with various yeast strains, including YER152C knockout strains

  • Pre-adsorb the antibody with purified recombinant YER152C protein to confirm specificity

  • Conduct immunoprecipitation followed by mass spectrometry to identify all proteins captured

• Mitigation strategies:

  • Use higher dilutions of antibody to reduce non-specific binding

  • Increase blocking agent concentration in assay buffers

  • Pre-clear lysates with protein A/G beads before immunoprecipitation

  • Consider affinity purification of the antibody against the immunogen

  • Include competing peptides in control reactions to confirm epitope specificity

Cross-reactivity analysis is particularly important when studying protein families with conserved domains or when investigating novel sample types.

How can researchers validate epitope accessibility in different experimental conditions?

Epitope accessibility can vary based on protein folding, fixation methods, and experimental conditions. To validate epitope accessibility:

• Compare native vs. denatured conditions:

  • Test antibody in native conditions (e.g., immunoprecipitation, native PAGE)

  • Compare with denatured conditions (e.g., SDS-PAGE, Western blot)

  • If the antibody only works in denatured conditions, the epitope may be internal

• Fixation method optimization:

  • Compare different fixation methods (paraformaldehyde, methanol, acetone) when using the antibody for immunofluorescence

  • Test different fixation durations and concentrations

• Antigen retrieval approaches:

  • Evaluate heat-induced epitope retrieval

  • Test pH-dependent epitope recovery methods

  • Consider enzymatic antigen retrieval methods

These validation steps are essential as epitope accessibility directly impacts experimental outcomes, especially when comparing results across different experimental platforms .

How can researchers quantitatively assess YER152C antibody performance across different lots?

Antibody lot-to-lot variation can significantly impact experimental reproducibility. A systematic approach to assess performance includes:

• Quantitative performance metrics:

  • Titration curves to determine optimal working concentration

  • Signal-to-noise ratio measurement across a concentration range

  • Analysis of detection limits using serial dilutions of purified target

  • Western blot band intensity quantification using reference standards

  • ELISA standard curves with known amounts of target protein

• Consistency validation:

  • Create a reference sample set that can be tested with each new lot

  • Maintain a standard operating procedure for validation

  • Document acceptance criteria for each application

  • Consider developing an immunosignature profile specific to your antibody

Researchers should maintain detailed records of lot numbers and performance characteristics to track and account for potential variations in experimental results.

How might post-translational modifications of YER152C affect antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition of target proteins:

• Common PTMs in yeast proteins:

  • Phosphorylation

  • Ubiquitination

  • Sumoylation

  • Glycosylation

  • Acetylation

• Assessment strategies:

  • Compare antibody recognition of native vs. recombinant protein (which may lack PTMs)

  • Use phosphatase treatment to remove phosphorylation

  • Apply specific PTM-removing enzymes before antibody detection

  • Create separate samples enriched for different PTM states

• Experimental approaches:

  • Use antibodies specifically developed against modified forms

  • Combine immunoprecipitation with mass spectrometry to identify modifications

  • Perform 2D gel electrophoresis to separate protein isoforms

Understanding how PTMs affect antibody binding is crucial for correctly interpreting experimental results, particularly when studying protein regulation mechanisms or stress responses in yeast .

What are the optimal Western blot conditions for YER152C antibody?

Optimizing Western blot conditions for YER152C antibody detection requires attention to several parameters:

These conditions should be optimized for each specific experimental system. The antibody is purified using antigen affinity methods, which should provide good specificity for Western blot applications .

How can researchers troubleshoot weak or absent signals when using YER152C antibodies?

When experiencing weak or absent signals with YER152C antibodies, a systematic troubleshooting approach is recommended:

• Antibody-related factors:

  • Verify antibody concentration and increase if necessary

  • Check antibody storage conditions and potential degradation

  • Test a new lot or aliquot of antibody

  • Extend primary antibody incubation time

• Sample-related factors:

  • Confirm protein expression in your sample

  • Increase protein loading amount

  • Verify sample preparation method preserves protein integrity

  • Check for protease inhibitors in lysis buffers

• Assay conditions:

  • Optimize blocking conditions (agent type, concentration, duration)

  • Adjust buffer compositions (salt concentration, detergent level)

  • Modify washing stringency

  • Test different detection systems with varying sensitivity

• Target-specific considerations:

  • Verify YER152C expression under your experimental conditions

  • Consider if target protein might be modified or degraded

  • Assess if protein extraction method is appropriate for your subcellular compartment

Systematic testing of these variables while changing one parameter at a time will help identify the source of weak signals .

What methods can be used to determine the exact epitope recognized by a YER152C antibody?

Determining the specific epitope recognized by a YER152C antibody is valuable for understanding its binding characteristics and potential limitations:

• Peptide mapping approaches:

  • Create an overlapping peptide array covering the YER152C sequence

  • Test antibody binding to each peptide fragment

  • Identify the minimal peptide sequence recognized by the antibody

• Mutagenesis strategies:

  • Generate point mutations or deletions in recombinant YER152C

  • Express mutant proteins and test antibody binding

  • Map critical residues required for antibody recognition

• Proteolytic fragmentation:

  • Digest purified YER152C with various proteases

  • Analyze which fragments are recognized by the antibody

  • Sequence the recognized fragments to identify the epitope region

• Competitive binding assays:

  • Design synthetic peptides based on predicted epitopes

  • Test their ability to block antibody binding to full-length protein

  • Quantify competitive binding to determine epitope specificity

Understanding the specific epitope can help predict potential cross-reactivity, explain differences in assay performance, and guide experimental design.

How can YER152C antibodies be validated for immunoprecipitation experiments?

Validating YER152C antibodies for immunoprecipitation (IP) requires specific procedures to ensure reliability:

• Initial validation experiments:

  • Perform IP followed by Western blot detection with the same or different antibody

  • Include appropriate controls (IgG control, lysate input)

  • Optimize antibody amount, bead type, and binding conditions

• Advanced validation:

  • Conduct IP-mass spectrometry to identify all proteins captured

  • Compare results between wild-type and YER152C knockout strains

  • Assess enrichment factor by comparing input vs. IP samples

• Optimization parameters:

  • Test different lysis buffers (varying detergent types and concentrations)

  • Compare various antibody coupling methods to beads

  • Evaluate different washing stringencies to balance specificity vs. yield

• Application-specific considerations:

  • For protein-protein interaction studies, optimize conditions to preserve complexes

  • For chromatin immunoprecipitation, ensure appropriate crosslinking and sonication

  • For co-IP experiments, verify that buffer conditions maintain relevant interactions

Documentation of these validation steps is essential for publication and ensuring reproducible results in downstream applications.

How can researchers differentiate between specific and non-specific binding in immunoassays using YER152C antibody?

Distinguishing specific from non-specific binding is critical for accurate data interpretation:

• Experimental approaches:

  • Compare signal between wild-type and YER152C deletion strains

  • Use peptide competition assays to block specific binding

  • Evaluate signal in tissues/cells known not to express the target

  • Compare results using multiple antibodies targeting different epitopes

• Analysis methods:

  • Quantify signal-to-noise ratios across different antibody dilutions

  • Apply statistical thresholds based on negative control distributions

  • Consider using machine learning algorithms for pattern recognition in complex datasets

• Control implementations:

  • Use isotype control antibodies at equivalent concentrations

  • Include secondary-only controls to assess non-specific binding

  • Pre-adsorb antibody with recombinant target to confirm specificity

Specific binding typically shows dose-dependency, saturability, and can be competitively inhibited by the target antigen, while non-specific binding often lacks these characteristics.

How should researchers interpret contradictory results when using YER152C antibodies across different experimental platforms?

When facing contradictory results across different experimental platforms:

• Systematic investigation approach:

  • Document all experimental variables between platforms (buffers, temperatures, incubation times)

  • Consider epitope accessibility differences between applications

  • Evaluate protein conformational states in each platform

• Technical considerations:

  • Different detection limits between platforms may explain discrepancies

  • Sample preparation methods may affect protein structure or epitope exposure

  • Platform-specific interfering substances might be present

• Resolution strategies:

  • Use orthogonal detection methods to verify results

  • Employ multiple antibodies targeting different epitopes

  • Consider using tagged versions of the protein for verification

  • Design experiments that can validate findings in living cells

Contradictory results often reveal important biological insights about protein conformation, interactions, or modifications rather than simply representing technical errors.

What are best practices for quantifying YER152C expression levels using antibody-based assays?

Accurate quantification of YER152C expression requires rigorous methodological approaches:

• Quantitative Western blot best practices:

  • Include serial dilutions of recombinant YER152C standard

  • Ensure detection is within linear range of response

  • Use digital imaging rather than film for quantification

  • Normalize to multiple housekeeping proteins

  • Apply appropriate statistical analysis to biological replicates

• ELISA/quantitative immunoassay considerations:

  • Develop standard curves with purified YER152C protein

  • Verify parallel dilution behavior between standards and samples

  • Account for matrix effects in complex samples

  • Use four-parameter logistic regression for curve fitting

• Flow cytometry/imaging quantification:

  • Use appropriate negative controls to set thresholds

  • Include calibration beads for fluorescence standardization

  • Apply consistent gating strategies across experiments

  • Consider single-cell variability in analysis

Comprehensive quantification should include measures of technical and biological variability, and results should be presented with appropriate statistics and effect sizes.

How might emerging antibody technologies improve YER152C detection and analysis?

Emerging technologies offer new possibilities for YER152C research:

• Advanced antibody formats:

  • Single-domain antibodies (nanobodies) for accessing restricted epitopes

  • Recombinant antibody fragments with enhanced specificity

  • Bispecific antibodies for co-detection of interacting partners

• Novel detection platforms:

  • Single-molecule detection methods for increased sensitivity

  • Super-resolution microscopy compatible antibody conjugates

  • Proximity labeling approaches for in situ protein interaction studies

• Antibody engineering improvements:

  • Site-specific conjugation for optimal orientation

  • Reduced background through engineered constant regions

  • Improved stability for harsh experimental conditions

Researchers should monitor literature for validation of these technologies with yeast proteins and consider collaborative approaches to implement cutting-edge methods.

What considerations are important when developing custom YER152C antibodies for specialized research applications?

Developing custom antibodies for specialized YER152C research requires careful planning:

• Immunogen design strategies:

  • Select unique regions with high antigenicity

  • Consider using multiple peptides targeting different domains

  • Evaluate species conservation if cross-reactivity is desired

  • Design constructs that maintain native conformation

• Production approach selection:

  • Polyclonal: Broader epitope recognition but potential batch variation

  • Monoclonal: Consistent single-epitope recognition

  • Recombinant: Defined sequence with potential for engineering

• Validation requirements:

  • Define application-specific validation criteria

  • Plan for knockout/knockdown controls

  • Consider orthogonal detection methods

  • Document performance across different sample types

The investment in custom antibody development should be balanced against research goals, timeline, and available resources, with comprehensive validation being essential regardless of approach.

What are the key considerations for ensuring reproducible research with YER152C antibodies?

Ensuring reproducibility when working with YER152C antibodies requires attention to several factors:

• Documentation practices:

  • Record complete antibody information (supplier, catalog number, lot, clone)

  • Document detailed protocols including all buffer compositions

  • Maintain comprehensive experimental conditions (incubation times, temperatures)

  • Preserve original data files and analysis methods

• Validation approaches:

  • Implement multiple controls appropriate to each experiment

  • Verify antibody performance in your specific system

  • Validate key findings with orthogonal methods

  • Consider independent replication of critical experiments

• Reporting standards:

  • Follow field-specific guidelines for antibody reporting

  • Include validation data in publications or supplementary materials

  • Specify exact experimental conditions that may affect reproducibility

  • Share detailed protocols through repositories

These practices not only enhance the reliability of individual research findings but contribute to the broader scientific understanding of YER152C function in yeast biology.

How should researchers integrate YER152C antibody data with other omics approaches for comprehensive analysis?

Integrating antibody-based data with other omics approaches provides a more complete understanding:

• Multi-omics integration strategies:

  • Correlate protein detection with transcriptomic data

  • Combine with proteomic mass spectrometry for validation

  • Integrate with genetic interaction screens

  • Incorporate structural biology data for functional interpretation

• Computational approaches:

  • Apply network analysis to place YER152C in biological pathways

  • Use machine learning to identify patterns across datasets

  • Develop predictive models incorporating multiple data types

  • Implement visualization tools for integrated data interpretation

• Experimental design considerations:

  • Plan for sample compatibility across different platforms

  • Include shared controls across methodologies

  • Consider time-course analyses to capture dynamic processes

  • Design experiments that test predictions from integrated analyses